Want to join the conversation?
$AWK's earnings from continuing operations in Regulated Businesses for 1Q16 rose to $87MM from $81MM last year. The increase is primarily attributable to revenue growth of 3.1% on infrastructure investment and acquisitions. Partially offset by higher depreciation and amortization expense associated with infrastructure investment growth.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.